What They List
- Psilocybin Clinical Trial
- Study Screening Information
- Research Participation Details
Research
NCT05995769 - Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
Clinical Trial in Calgary, Alberta
The aim of this study is to determine if a single dose of psilocybin administered with motivational enhancement therapy (MET) can reduce heavy drinking in patients with an alcohol use disorder (AUD). Source record lists lead sponsor University of Calgary and overall status Recruiting.
Clinical TrialResearch
Directory Facts
- Status
- Verified from official/source records
- Price
- Free study screening / research participation
- Hours
- Verify with provider
- License / Record
- NCT05995769
- Last Verified
- 2026-06-12
Location
University of Calgary, Calgary, Alberta
Source Notes
Discovery row generated from the official ClinicalTrials.gov API record for NCT05995769; status Recruiting; sponsor University of Calgary.
Source: https://clinicaltrials.gov/study/NCT05995769
MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.